Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Chan, Kwok H. ; Poon, Leo L.L.M. ; Cheng, V.C.C. ; Guan, Yi ; Hung, I.F.N. ; ... More +
Chan, Kwok H. ; Poon, Leo L.L.M. ; Cheng, V.C.C. ; Guan, Yi ; Hung, I.F.N. ; Kong, James ; Yam, Loretta Y.C. ; Seto, Wing H. ; Yuen, Kwok Y. ; Peiris, Joseph S. Malik Less -
Description:
Cases of severe acute respiratory syndrome (SARS) were investigated for SARS coronavirus (SARS-CoV) through RNA tests, serologic response, and viral culture. Of 537 specimens from patients in whom SARS was clinically diagnosed, 332 (60%) had SARS-CoV RNA in one or more clinical specimens, compared with 1 (0.3%) of 332 samples from controls. Of 417 patients with clinical SARS from whom paired serum samples were available, 92% had an antibody response. Rates of viral RNA positivity increased progressively and peaked at day 11 after onset of illness. Although viral RNA remained detectable in respiratory secretions and stool and urine specimens for >30 days in some patients, virus could not be cultured after week 3 of illness. Nasopharyngeal aspirates, throat swabs, or sputum samples were the most useful clinical specimens in the first 5 days of illness, but later in the illness viral RNA could be detected more readily in stool specimens.
Subjects:
[+]
Antibodies, Viral Diagnosis Epidemiology Humans Pathogenesis Research Reverse Transcriptase Polymerase Chain Reaction RNA, Viral SARS SARS Coronavirus SARS Virus Severe Acute Respiratory Syndrome Time Factors Transmission Virus
Source:
Emerg Infect Dis. 10(2):294-299.
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:e30fb7ccacbe786f93f687fefbab5a59cbd8c60773fbb1c234561efbfffd733e
Download URL:
https://stacks.cdc.gov/view/cdc/14452/cdc_14452_DS1.pdf
File Type:

Supporting Files

• 	03-0610-F.gif	gif
  	03-0610-F.jpg	jpeg
  	03-0610.nxml	txt
  	license.txt	txt

More +